1. The Role of Small Interfering RNAs in Hepatocellular Carcinoma
    Feng Chen et al, 2023, Journal of Gastrointestinal Cancer CrossRef
  2. Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
    Yezhe Cheng et al, 2022, Frontiers in Oncology CrossRef
  3. The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance
    Tomas Koltai et al, 2023, International Journal of Molecular Sciences CrossRef
  4. The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
    David M. Goldenberg et al, 2018, Oncotarget CrossRef
  5. CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer
    Zongxia Wang et al, 2021, Frontiers in Molecular Biosciences CrossRef
  6. Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
    Emanuele Perrone et al, 2020, Frontiers in Oncology CrossRef
  7. TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways
    Zhiping Yang et al, 2022, Current Cancer Drug Targets CrossRef
  8. Caffeic acid phenethyl ester inhibits the progression of ovarian cancer by regulating NF-κB signaling
    Ge-Lin Liu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  9. Personalized Treatment in Ovarian Cancer
    Nozomu Yanaihara et al, 2022, Personalization in Gynecologic Oncology CrossRef
  10. LAMB3 and TACSTD2, both highly expressed in salivary gland mucoepidermoid carcinoma, represent potential diagnostic biomarkers and therapeutic targets
    Kazunari Yoshida et al, 2023, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology CrossRef
  11. Calcium signals and potential therapy targets in ovarian cancer (Review)
    Fengying Deng et al, 2023, International Journal of Oncology CrossRef
  12. Trop2: Jack of All Trades, Master of None
    Sára Lenárt et al, 2020, Cancers CrossRef
  13. Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
    Mehrdad Hashemi et al, 2022, Life Sciences CrossRef
  14. Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
    Pasquale Lombardi et al, 2023, Cancers CrossRef
  15. TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling
    Qing‑Zhi Gu et al, 2018, Molecular Medicine Reports CrossRef
  16. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
    Xinlin Liu et al, 2022, Pharmacology & Therapeutics CrossRef
  17. Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
    Annie Ren et al, 2021, F1000Research CrossRef
  18. Subpopulation commensalism promotes Rac1-dependent invasion of single cells via laminin-332
    Sung Bo Yoon et al, 2024, Journal of Cell Biology CrossRef